✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Aarti Drugs Ltd.

AARTIDRUGS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,561 Cr.
P/E
17.89

Aarti Drugs Ltd.

  • Aarti Drugs
  • SMS Pharmaceuticals
  • Solara Active Pharma
  • TJI Pharma - Small Cap

FAQs on Aarti Drugs Ltd. Shareprice

Aarti Drugs has given lower returns compared to its competitors.
Aarti Drugs has grown at ~-5.2% over the last 3yrs while peers have grown at a median rate of 10.24%

Aarti Drugs is not expensive.
Latest PE of Aarti Drugs is 18.26, while 3 year average PE is 24.33.
Also latest EV/EBITDA of Aarti Drugs is 13.39 while 3yr average is 16.03.

View FAQ's On Business

Growth Table

  • Aarti Drugs Ltd.
  • SMS Pharmaceuticals
  • Solara Active Pharma

Balance Sheet

  • Aarti Drugs Ltd.
  • SMS Pharmaceuticals
  • Solara Active Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Aarti Drugs Ltd.
  • SMS Pharmaceuticals
  • Solara Active Pharma

Cash Flow

  • Aarti Drugs Ltd.
  • SMS Pharmaceuticals
  • Solara Active Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Aarti Drugs Ltd.
  • SMS Pharmaceuticals
  • Solara Active Pharma

Quarterly Results

  • Aarti Drugs Ltd.
  • SMS Pharmaceuticals
  • Solara Active Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Aarti Drugs Ltd. Financials

Balance sheet of Aarti Drugs is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Aarti Drugs is decreasing.
Latest net debt of Aarti Drugs is ₹562 Crs as of Sep-25.
This is less than Mar-25 when it was ₹600 Crs.

The profit is oscillating.
The profit of Aarti Drugs is ₹199 Crs for TTM, ₹168 Crs for Mar 2025 and ₹171 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aarti Drugs latest dividend payout ratio is 5.43% and 3yr average dividend payout ratio is 5.45%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech